Adolescent and pediatric gynecology: Edited by Paula J. Adams HillardAdolescents and emergency contraception update 2011Duffy, Kaiytia; Gold, Melanie A.b Author Information aUniversity of Illinois at Chicago, School of Medicine, Chicago, Illinois bPediatrics, Division of Adolescent Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA Correspondence to Melanie A. Gold, D.O., Clinical Professor of Pediatrics, Division of Adolescent Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Staff Physician, Division of Student Affairs, University of Pittsburgh Student Health Service, Medical Arts Building, Suite 500, 3708 Fifth Avenue, Pittsburgh, PA 15213, USATel: +1 412 383 1800; fax: +1 412 383 1807; e-mail: [email protected] Current Opinion in Obstetrics and Gynecology: October 2011 - Volume 23 - Issue 5 - p 328-333 doi: 10.1097/GCO.0b013e32834ad5a5 Buy Metrics Abstract Purpose of review This review presents the most up-to-date information regarding available methods, safety, efficacy, and availability of emergency contraception for adolescents. Recent findings Recent reanalysis suggests that previously reported efficacy rates for the levonorgestrel-only method emergency contraception were probably overestimated. A newer and more efficacious method of emergency contraception, ulipristal acetate, was FDA approved in August 2010. Summary Emergency contraception provides young women with an opportunity to prevent pregnancy in the event of unprotected sexual intercourse. Several dedicated products are available commercially in the USA with varying efficacy rates. Barriers, including cost and accessing emergency contraception within the designated time frame, often prevent use among young women. © 2011 Lippincott Williams & Wilkins, Inc.